Article • Expose the Heist: Power and Policy in Unprecedented Times
One More Iffy Trump Drug Deal
Donald Trump rolled out another drug pricing deal — but it’s still very unclear whether these arrangements provide any relief to consumers.
Article • Expose the Heist: Power and Policy in Unprecedented Times
Donald Trump rolled out another drug pricing deal — but it’s still very unclear whether these arrangements provide any relief to consumers.
Article • Expose the Heist: Power and Policy in Unprecedented Times
Trump’s ‘no tax on tips’ PR stunt revealed the empty promises behind the policy.
Article • Expose the Heist: Power and Policy in Unprecedented Times
A recent Supreme Court decision upended one Louisiana community’s power to hold Big Oil accountable.
Article • Expose the Heist: Power and Policy in Unprecedented Times
The administration’s Census plan presents a problem for overall Census validity and seems designed to fall hardest on groups that are already more likely to be undercounted.
Article • Expose the Heist: Power and Policy in Unprecedented Times
The Trump budget proposal seeks to slash funding for climate and environmental research that is crucial to understanding the threats we are facing.
Article • Expose the Heist: Power and Policy in Unprecedented Times
Thanks to the Republican war on the IRS, billionaire tax cheats are breathing easier.
Article • Expose the Heist: Power and Policy in Unprecedented Times
Reducing the US military budget would free up funds for programs that actually support people in this country, and would likely reduce the threat of future wars as well.
Article • Expose the Heist: Power and Policy in Unprecedented Times
A long-awaited Trump administration rule appears to give the private equity industry a valuable gift.
Article • Expose the Heist: Power and Policy in Unprecedented Times
Decades of a frozen tipped wage continues to shift labor costs onto customers while policy fixes do little to support the lowest-paid workers.
Article • Expose the Heist: Power and Policy in Unprecedented Times
Mounting evidence of overpayments and rising costs is driving growing bipartisan pushback against Medicare Advantage insurers.